Design of the Tocilizumab in Giant Cell Arteritis Trial

International Journal of Rheumatology - United States
doi 10.1155/2013/912562
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Glucocorticoid Doses and Acute-Phase Reactants at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2019English

Giant Cell Arteritis.

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1991English

Psy44 - Tocilizumab in Combination With Corticosteroids for the Treatment of Giant Cell Arteritis: A Budget Impact Analysis in Italy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Giant-Cell Arteritis of the Legs

BMJ
1955English

Psy108 - Cost-Utility Analysis of Tocilizumab in Combination With Corticosteroids for the Treatment of Giant Cell Arteritis in Italian Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Internuclear Ophthalmoplegia in Giant Cell Arteritis.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1992English

Giant Cell Arteritis: Authors' Reply

BMJ
1992English

Vascular Damage in Giant Cell Arteritis

Autoimmunity
AllergyImmunology
2009English

Neurological Manifestations of Giant Cell Arteritis

Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova
PsychiatryMental HealthNeurology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy